相似文献
1
Open conflict on the handling of the Merck drug Vioxx by editorial giants.
Reprod Biomed Online. 2006 Dec;13(6):905. doi: 10.1016/s1472-6483(10)61040-1.
2
3
What have we learnt from Vioxx?
BMJ. 2007 Jan 20;334(7585):120-3. doi: 10.1136/bmj.39024.487720.68.
4
Medical journal criticizes Merck over Vioxx data.
N Y Times Web. 2005 Dec 9:A1, C13.
5
Court hears how drug giant Merck tried to "neutralise" and "discredit" doctors critical of Vioxx.
BMJ. 2009 Apr 6;338:b1432. doi: 10.1136/bmj.b1432.
6
Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld.
Science. 2005 Dec 16;310(5755):1755. doi: 10.1126/science.310.5755.1755.
7
A message from the Vioxx case.
Am J Health Syst Pharm. 2006 Mar 15;63(6):503. doi: 10.2146/ajhp050427.
8
Quebec allows Vioxx class-action suit.
CMAJ. 2007 Jan 2;176(1):20. doi: 10.1503/cmaj.061600.
9
Merck's actions surrounding Vioxx.
PLoS Med. 2006 Jun;3(6):e286; author reply e285. doi: 10.1371/journal.pmed.0030286. Epub 2006 Jun 27.
10
Vioxx doctors wooed by Merck are now its foes.
Wall St J (East Ed). 2006 Mar 10:B1, B3.
Zotero 插件